ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bearishCelltrion Inc
01 Apr 2020 17:32

Celltrion+Celltrion Healthcare Placement- Discount Looks Enticing but the Deal Appears Opportunistic

Temasek plans to raise US$380m via selling 1.9% stake in Celltrion Healthcare (091990 KS) and another US$132m via selling a 1.5% stake in Celltrion...

Logo
371 Views
Share
01 Apr 2020 05:39

Short Covering Continues - Celltrion Leads The Way

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 27 March 2020, the...

Logo
307 Views
Share
31 Mar 2020 17:32

Korea Stock Market Monthly Recap #46 (March 2020)

The world will never be the same after COVID-19. We provided an extensive analysis of the on-going developments of COVID-19 in March. This novel...

Logo
310 Views
Share
31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
354 Views
Share
24 Mar 2020 17:51

Short Covering - The New Normal

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 20 March 2020, the...

Logo
337 Views
Share
x